Landulosin, 0.5 mg + 0.4 mg, hard capsules
Dutasteride + Tamsulosin hydrochloride
Landulosin is used to treat an enlarged prostate(benign prostatic hyperplasia)- a non-cancerous enlargement of the prostate caused by excessive production of a hormone called dihydrotestosterone.
Landulosin is a combination of two other medicines: dutasteride and tamsulosin. Dutasteride belongs to a group of medicines called 5-alpha-reductase inhibitors, and tamsulosin belongs to a group of medicines called alpha-adrenergic receptor antagonists.
Enlargement of the prostate can lead to problems with urination, such as difficulty urinating and frequent urination. It can also cause a decrease in urine flow and a weak urine stream. If left untreated, it can lead to complete blockage of urine flow (acute urinary retention). This situation requires immediate treatment. In some cases, surgical intervention may be necessary to remove the prostate or reduce its size.
Dutasteride reduces the production of the hormone dihydrotestosterone, which causes the prostate to shrink and alleviates symptoms. By doing so, dutasteride reduces the risk of acute urinary retention and the need for surgical intervention. Tamsulosin works by relaxing the muscles in the prostate, making it easier for urine to flow and providing quick relief from symptoms.
You should discuss the use of Landulosin with your doctor before starting treatment.
If you have any further questions about the use of Landulosin, you should consult your doctor or pharmacist.
You should tell your doctor or pharmacist about all medicines you are taking or have recently taken, including those available without a prescription.
It is not recommended to take Landulosin with the following medicines:
Some medicines may interact with Landulosin, which may increase the risk of side effects. These medicines include:
Landulosin should be taken 30 minutes after the same meal each day.
Landulosin must not be taken by women.
Dutasteride is absorbed through the skin and may affect the development of a male fetus. There is a particular risk during the first 16 weeks of pregnancy.
You should use a condom during sexual intercourse.Dutasteride has been found in the semen of men taking Landulosin. If your partner is pregnant or may become pregnant, you should avoid exposing her to your semen.
It has been shown that the combination of dutasteride and tamsulosin reduces sperm count, semen volume, and sperm motility, which may lead to reduced fertility in men.
If a pregnant woman has come into contact with Landulosin, she should consult her doctor.
Landulosin may cause dizziness in some patients, which may affect their ability to drive or operate machinery.
If you experience such symptoms, you should not drive or operate machinery.
The medicine contains soy lecithin, which may contain soybean oil. If you are allergic to peanuts or soy, you should not take this medicinal product.
The medicine contains less than 1 mmol of sodium (23 mg) per capsule, which means that it is essentially 'sodium-free'.
The medicine contains 229 mg of propylene glycol in each capsule.
If you do not take the medicine regularly, it may affect the results of your PSA tests.
If you are unsure, you should ask your doctor or pharmacist.
The capsule should be swallowed whole with water.The capsule should not be chewed, crushed, or opened. Contact with the contents of the capsule may cause mouth or throat pain.
If you take more than the recommended dose of Landulosin, you should consult your doctor or pharmacist.
You should not take a double dose to make up for a missed dose. You should take the next capsule at the usual time.
You should not stop taking the medicine without consulting your doctor first.
If you have any further questions about the use of this medicine, you should ask your doctor or pharmacist.
Symptoms of an allergic reaction may include:
Landulosin may cause dizziness, lightheadedness, and fainting. Until you know how the medicine affects you, you should be careful when changing positions from sitting or lying down to standing, especially when getting up at night. If you experience dizziness or lightheadedness during treatment, you should sit or lie down and wait for the symptoms to pass.
Symptoms of severe skin reactions may include:
Common side effects(may affect up to 1 in 10 people)
*In a small number of people, some of these side effects may persist even after stopping treatment with Landulosin.
Uncommon side effects(may affect up to 1 in 100 people)
Very rare side effects(may affect up to 1 in 10,000 people)
Other side effects have been reported in a small number of men, but the frequency of these side effects is not known (cannot be estimated from the available data)
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the:
Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be kept out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after EXP.
The expiry date refers to the last day of the month.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Hard capsule shell:
Black iron oxide (E 172)
Red iron oxide (E 172)
Titanium dioxide (E 171)
Yellow iron oxide (E 172)
Gelatin
Soft capsule contents:
Propylene glycol monocaprylate, type II
Butylhydroxytoluene (E 321)
Soft capsule shell:
Gelatin
Glycerol
Titanium dioxide (E 171)
Saturated fatty acid triglycerides
Soy lecithin (see section 2)
Tamsulosin pellets:
Methacrylic acid and ethyl acrylate copolymer (1:1) dispersion 30% (contains sodium lauryl sulfate and polysorbate 80)
Microcrystalline cellulose
Dibutyl sebacate
Polysorbate 80
Silica, colloidal, hydrated
Calcium stearate
Black ink:
Shellac
Black iron oxide (E 172)
Propylene glycol
Ammonium hydroxide
Potassium hydroxide
See section 2 "Landulosin contains soy lecithin, propylene glycol, and sodium".
Landulosin is a hard, gelatin capsule, approximately 24.2 mm x 7.7 mm in size, with a brown body and a beige cap, printed with black ink with the code C001.
Each hard capsule contains tamsulosin pellets with modified release and one soft gelatin capsule of dutasteride.
Landulosin is available in packs of 30 capsules.
G.L. Pharma GmbH
Schlossplatz 1,
8502 Lannach,
Austria
G.L. Pharma GmbH
Schlossplatz 1,
8502 Lannach,
Austria
Laboratorios LEÓN FARMA, SA
C/La Vallina, s/n, Polígono Industrial Navatejera
Villaquilambre-24193 (León)
Spain
Czech Republic: Aglandut
Denmark: Dutasterid/Tamsulosinhydrochlorid G.L. Pharma
Lithuania: Dutamsin
Poland: Landulosin
Slovakia: Aglandin
Hungary: Aglandin
G.L. PHARMA POLAND Sp. z o.o.
ul. Sienna 75; 00-833 Warsaw, Poland
Phone: 022/ 636 52 23; 636 53 02
[email protected]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Landulosin – subject to medical assessment and local rules.